These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 18544305)
1. Management of anticoagulation and platelet inhibition in reconstructive vascular surgery. Comerota AJ; Thakur S Vascular; 2008; 16 Suppl 1():S48-54. PubMed ID: 18544305 [TBL] [Abstract][Full Text] [Related]
2. [Peripheral arterial revascularization: which antithrombotic agents?]. Haulon S; Susen S; Koussa M; Jude B Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970 [TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins. Dagher NN; Modrall JG Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359 [TBL] [Abstract][Full Text] [Related]
4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
5. Management of surgical patients receiving anticoagulation and antiplatelet agents. Thachil J; Gatt A; Martlew V Br J Surg; 2008 Dec; 95(12):1437-48. PubMed ID: 18991253 [TBL] [Abstract][Full Text] [Related]
6. [Low molecular weight heparin in patients undergoing vascular surgery]. Godet G; Kretz JG; Cristea T Ann Fr Anesth Reanim; 2005 Apr; 24(4):347-54. PubMed ID: 15826784 [TBL] [Abstract][Full Text] [Related]
7. Postoperative anticoagulation in vascular surgery: part 1. A retrospective comparison of clinical outcomes for unfractionated heparin versus low-molecular-weight heparin. Gramse CA; Hingorani A; Ascher E J Vasc Nurs; 2001 Jun; 19(2):42-9; quiz 50-1. PubMed ID: 11395717 [TBL] [Abstract][Full Text] [Related]
12. Management of anticoagulation therapy for invasive procedures. Gaines KK Urol Nurs; 2005 Oct; 25(5):379-80. PubMed ID: 16294616 [No Abstract] [Full Text] [Related]
13. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Helft G; Gilard M; Le Feuvre C; Zaman AG Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800 [TBL] [Abstract][Full Text] [Related]
14. Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation. Spyropoulos AC; Douketis JD Int Angiol; 2008 Aug; 27(4):333-43. PubMed ID: 18677297 [No Abstract] [Full Text] [Related]
16. [Longterm treatment of POAD with anticoagulants and platelet inhibitors after endovascular procedures and vascular surgery: what is evidence based?]. Landgraf H Hamostaseologie; 2006 Aug; 26(3):239-44; quiz 245-6. PubMed ID: 16906242 [TBL] [Abstract][Full Text] [Related]
17. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative. Wang TY; Chen AY; Peterson ED; Becker RC; Gibler WB; Ohman EM; Roe MT Eur Heart J; 2008 May; 29(9):1103-9. PubMed ID: 18353757 [TBL] [Abstract][Full Text] [Related]
19. Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention. Scharf RE Hamostaseologie; 2009 Nov; 29(4):388-98. PubMed ID: 19882082 [TBL] [Abstract][Full Text] [Related]
20. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices. Faxon DP Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]